Emergent Financial Statements From 2010 to 2024

EBS Stock  USD 2.59  0.15  6.15%   
Emergent Biosolutions financial statements provide useful quarterly and yearly information to potential Emergent Biosolutions investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Emergent Biosolutions financial statements helps investors assess Emergent Biosolutions' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Emergent Biosolutions' valuation are summarized below:
Gross Profit
290.1 M
Profit Margin
(0.72)
Market Capitalization
127.4 M
Enterprise Value Revenue
0.8562
Revenue
B
There are over one hundred nineteen available fundamental signals for Emergent Biosolutions, which can be analyzed over time and compared to other ratios. All traders should verify Emergent Biosolutions' prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.
Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent main balance sheet or income statement drivers, such as Depreciation And Amortization of 158.9 M, Interest Expense of 45 M or Total Revenue of 1.4 B, as well as many exotic indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.019 or Operating Cycle of 386. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.
  
This module can also supplement Emergent Biosolutions' financial leverage analysis and stock options assessment as well as various Emergent Biosolutions Technical models . Check out the analysis of Emergent Biosolutions Correlation against competitors.
For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

Emergent Biosolutions Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.8 B3.6 B1.8 B
Slightly volatile
Short and Long Term Debt Total1.7 B1.6 B603 M
Slightly volatile
Other Current Liabilities149.8 M142.7 M69.5 M
Slightly volatile
Total Current Liabilities1.5 B1.4 B418.5 M
Slightly volatile
Property Plant And Equipment Net987.3 M940.2 M535.4 M
Slightly volatile
Retained Earnings886.3 M844.1 M504.3 M
Slightly volatile
Accounts Payable61.2 M119 M74.9 M
Slightly volatile
Cash775.9 M739 M343.3 M
Slightly volatile
Non Current Assets Total2.4 B2.2 B1.2 B
Slightly volatile
Non Currrent Assets Other231 M220 M70.5 M
Slightly volatile
Cash And Short Term Investments775.9 M739 M343.4 M
Slightly volatile
Net Receivables134.3 M182.2 M165.7 M
Slightly volatile
Good Will142.3 M250.9 M140.7 M
Slightly volatile
Common Stock Shares Outstanding41.4 M57.6 M45.4 M
Slightly volatile
Liabilities And Stockholders Equity3.8 B3.6 B1.8 B
Slightly volatile
Non Current Liabilities Total396.4 M636.8 M520.5 M
Slightly volatile
Inventory424.8 M404.6 M198.5 M
Slightly volatile
Other Current Assets69.9 M66.6 M33.7 M
Slightly volatile
Total Liabilities2.2 B2.1 B865.3 M
Slightly volatile
Total Current Assets1.5 B1.4 B786.2 M
Slightly volatile
Short Term Debt1.2 B1.1 B234.5 M
Slightly volatile
Intangible Assets880 M838.1 M432.4 M
Slightly volatile
Common Stock61.4 K115 K70.3 K
Slightly volatile
Other Liabilities66.7 M104 M82 M
Slightly volatile
Current Deferred Revenue28.1 M30.4 M35.1 M
Slightly volatile
Long Term Debt290.2 M446.5 M358 M
Slightly volatile
Common Stock Total Equity120.8 K115 K68.8 K
Slightly volatile
Property Plant And Equipment Gross833.9 M794.2 M474.3 M
Slightly volatile
Property Plant Equipment987.3 M940.2 M494.2 M
Slightly volatile
Net Tangible AssetsB1.6 B897.6 M
Slightly volatile
Long Term Debt Total520.5 M515.8 M382.2 M
Slightly volatile
Capital Surpluse663.5 MB543.9 M
Slightly volatile
Non Current Liabilities Other27.5 M28.9 M52.8 M
Slightly volatile
Short and Long Term Debt219 M413.7 M214.2 M
Pretty Stable
Deferred Long Term Asset ChargesM10.2 M11.1 M
Slightly volatile
Cash And Equivalents403.8 M739 M356.1 M
Slightly volatile
Net Invested Capital2.2 B1.5 B1.5 B
Slightly volatile
Capital Stock80 K90 K98 K
Slightly volatile

Emergent Biosolutions Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization158.9 M151.3 M72.9 M
Slightly volatile
Total Revenue1.4 B1.3 B795.7 M
Slightly volatile
Other Operating Expenses1.6 B1.5 B814.1 M
Slightly volatile
Research Development132.3 M221.9 M163.5 M
Slightly volatile
Cost Of Revenue837.6 M797.8 M367.4 M
Slightly volatile
Total Operating Expenses716.3 M682.2 M446.7 M
Slightly volatile
Income Tax Expense2.3 M2.4 M26.3 M
Pretty Stable
Selling General Administrative391.5 M372.9 M204.6 M
Slightly volatile
Tax Provision48.4 M49.4 M44.4 M
Very volatile
Interest Income22 M42.9 M17 M
Slightly volatile
Reconciled Depreciation114.4 M131.2 M76 M
Slightly volatile

Emergent Biosolutions Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation54.5 M51.9 M26 M
Slightly volatile
Begin Period Cash Flow695.9 M662.7 M301.5 M
Slightly volatile
Depreciation173 M164.8 M72.2 M
Slightly volatile
Capital Expenditures71.4 M133.2 M81.3 M
Slightly volatile
End Period Cash Flow775.9 M739 M343.4 M
Slightly volatile
Change To Netincome44.4 M48.1 M38.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.110.11712.2968
Slightly volatile
Dividend Yield0.0190.00970.0049
Pretty Stable
Operating Cycle386225400
Slightly volatile
Days Of Payables Outstanding51.4154.1134120
Slightly volatile
Inventory Turnover2.422.3012.1451
Pretty Stable
Ebt Per Ebit4.464.25121.4538
Slightly volatile
Payables Turnover7.086.74514.052
Slightly volatile
Long Term Debt To Capitalization0.430.40750.2817
Slightly volatile
Cash Per Share3.792.18165.797
Slightly volatile
Total Debt To Capitalization0.540.57091.8056
Slightly volatile
Quick Ratio0.440.46482.4887
Slightly volatile
Net Income Per E B T0.591.04010.755
Very volatile
Cash Ratio0.160.17151.5564
Slightly volatile
Days Of Inventory Outstanding206159190
Pretty Stable
Days Of Sales Outstanding63.1266.4395202
Slightly volatile
Current Ratio0.991.04333.4197
Slightly volatile
Fixed Asset Turnover1.972.62981.5741
Slightly volatile
Debt Ratio0.320.47070.3425
Pretty Stable
Price Sales Ratio0.110.11712.2968
Slightly volatile
Receivables Turnover7.045.49374.6408
Slightly volatile
Asset Turnover0.870.57190.6035
Slightly volatile

Emergent Fundamental Market Drivers

Forward Price Earnings7.9428
Cash And Short Term Investments642.6 M

Emergent Upcoming Events

26th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Emergent Biosolutions Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Emergent Biosolutions income statement, its balance sheet, and the statement of cash flows. Emergent Biosolutions investors use historical funamental indicators, such as Emergent Biosolutions's revenue or net income, to determine how well the company is positioned to perform in the future. Although Emergent Biosolutions investors may use each financial statement separately, they are all related. The changes in Emergent Biosolutions's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Emergent Biosolutions's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Emergent Biosolutions Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Emergent Biosolutions. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue30.4 M28.1 M
Total Revenue1.3 B1.4 B
Cost Of Revenue797.8 M837.6 M
Ebit Per Revenue(0.16)(0.16)

Emergent Biosolutions Investors Sentiment

The influence of Emergent Biosolutions' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Emergent. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Emergent Biosolutions' public news can be used to forecast risks associated with an investment in Emergent. The trend in average sentiment can be used to explain how an investor holding Emergent can time the market purely based on public headlines and social activities around Emergent Biosolutions. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Emergent Biosolutions' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Emergent Biosolutions' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Emergent Biosolutions' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Emergent Biosolutions.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Emergent Biosolutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Emergent Biosolutions' short interest history, or implied volatility extrapolated from Emergent Biosolutions options trading.

Pair Trading with Emergent Biosolutions

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emergent Biosolutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will appreciate offsetting losses from the drop in the long position's value.

Moving against Emergent Stock

  0.69VBIV VBI Vaccines Financial Report 20th of May 2024 PairCorr
  0.66TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.44KA Kineta Inc Report 29th of March 2024 PairCorr
The ability to find closely correlated positions to Emergent Biosolutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emergent Biosolutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emergent Biosolutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emergent Biosolutions to buy it.
The correlation of Emergent Biosolutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emergent Biosolutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emergent Biosolutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emergent Biosolutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Emergent Biosolutions is a strong investment it is important to analyze Emergent Biosolutions' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Emergent Biosolutions' future performance. For an informed investment choice regarding Emergent Stock, refer to the following important reports:
Check out the analysis of Emergent Biosolutions Correlation against competitors.
For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.
Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Emergent Stock analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.022
Earnings Share
(14.85)
Revenue Per Share
20.494
Quarterly Revenue Growth
(0.16)
Return On Assets
(0.05)
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if Emergent Biosolutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.